ANDRES BONIFACIO COLLEGE

School of Nursing

A CASE PRESENTATION OF A
PATIENT WITH MYOMA UTERINE

Presented to: MS. RHODORA R. MORADOS R.N.

Presented by:
MS. IRISH C. EDOMBINGO
BSN – III-A
 OVERVIEW

Uterine fibroid tumors or leiomyomas are among the most common tumors among
women. In fact, it is apparent in 25-50% of women. Uterine fibroid tumors are typically non-
cancerous.

Uterine fibroid tumors, medically known as uterine leiomyomata or simply myoma,

are growths consisting of smooth muscle cells and fibrous connective tissues usually found
within the wall of the uterus. Some grow below the lining of the uterus; some grow between the
muscles of the uterus, while some grow towards the exterior part of the uterus. Uterine fibroid
tumors may grow in clusters or as a single nodule and may vary in size.

Scientific researches have not yet finally identified the causes of uterine fibroid
tumors. It has been theorized though that uterine fibroid tumors result from hormonal, genetic
and environmental factors, which may be present in combinations in every case.

Though considered as tumors, uterine fibroid tumors are mostly benign, which
means that in most instances, they are not as dangerous as cancerous tumors. Cases of uterine
fibroid tumors turning into cancer is very rare, however, it is possible. Although having uterine
fibroid tumors is generally not dangerous (it also has nothing to do with cancer of the uterus), it
is uneasy to live with; hence, women opt to have their uterine fibroid tumors removed.

In most instances, uterine fibroid tumors develop in women of childbearing age,

usually those in the 30s and 40s. However, researches show that women who have previously
given birth are less likely to develop uterine fibroid tumors. In addition, it has been found out
that overweight women and young African women are more prone to developing uterine fibroid
tumors. The reasons for these are not yet known, however, these facts have been prevalently
observed.

In many instances, uterine fibroid tumors do not cause symptoms, but some women
having these benign tumors say they experience pain and heavy bleeding during menstrual
periods while some experience bleeding in between their menstrual period. She also urinates
more often (due to the pressure of the fibroids to the bladder) and feels full in the lower part of
the abdomen.

Some women also experience pain in the lower back and pain during intercourse.
Other signs of uterine fibroid tumors include miscarriage, complications during pregnancy and
infertility.

Uterine fibroid tumors are detected through pelvic examination. This lets your
doctor check your vagina, ovaries and uterus. Imaging tests such as ultrasound, MRI (magnetic
resonance imaging), x-rays, and CT scan can also help the doctor detect presence of uterine
fibroid tumors in your uterus.

Treatment of the uterine fibroid tumors is not necessary however since symptoms
can be severe on some women, they prefer to have their fibroids treated. The main treatment for
uterine fibroid tumors is uterine fibroid embolization (UFE). This is a modestly invasive
procedure wherein a small tube is inserted into an artery towards the uterine artery. This allows
the interventional radiologist to bring in small plastic beads into the artery supplying blood to the
uterine fibroid tumors. In this way, blood flow to the uterine fibroid tumor is blocked causing it
to shrink; hence, symptoms are relieved.
 GENERAL OBJECTIVE
At the end of my case presentation, the listeners would be able to
gain knowledge and understand the case of a patient with Myoma
Uterine, also to enhance skills in differentiating the difference of
uterine myoma and also to improve their attitude towards patients
with the same case as mine and in caring for the patients with this
kind of case.

SPECIFIC OBJECTIVES

At the end of my discussion the listeners would be able to:

1. Identify and understand my patient’s case.

2. Know the clinical manifestations of the illness.

3. Determine the different treatment for this case.

4. Identify the diagnostic test to be done.

5. Differentiate the normal from abnormal findings in my patients

laboratory results.

6. Know the care plans for patients with this case.

7. Trace and understand the Pathophysiology.

8. Review the Anatomy and Physiology of the Reproductive System.

 BIBLIOGRAPHY

• http://www.nottingham.ac.uk/nursing/sonet/rlos/bioproc/resources.html

• http://www.le.ac.uk/pa/teach/va/anatomy/case2/frmst2.html

• http://www.medscape.com

• Barbara Howard, Clinical and Pathologic Microbiology, 2nd Edition

• Pathology 3rd Edition by Stanley L. Robbins, M.D.

• Tortora et. Al., Microbiology An Introduction, 8th Edition

• Deglin, Judith H., Vallerand, April H. Davis’s Drug Guide for Nurses, 10th ed.

F.A. Davis Company, Philadelphia, Pennsylvania,2007.

• Bullock, B. Henze, R. Focus on Pathophysiology. Philadelphia,

USA:Lippincott,

o Williams and Wilkins 2006.

• Clinical Applications of Nursing Diagnoses. F.A. Davis Company,

Philadelphia.

o 4th edition.

• Bare, Brenda G., Cheever, Kerry H., Hinkle, Janice L., Smeltzer, Suzanne C.

o Brunner & Suddarth’s Textbook of Medical- Surgical Nursing, 11 th ed.

Vol.1.

o Lippincott Williams & Wilkins, 2008.

• Doenges, Marilynn E., Moorhouse, Mary Frances, Murr, Alice C. Nursing Care

o Plans 7th ed. F.A. Davis Company, Philadelphia, Pennsylvania,2006.

• Karch, Amy M. 2007 Lippincott’s Nursing Drug Guide. Lippincott Williams &

o Wilkins, 2007.

• Porth, Carol M. Essentials of Pathophysiology: Concepts of Altered Health

States.
o 2nd ed. Lippincott Williams & Wilkins, 2007.